PitchBook

Nora Therapeutics Company Profile

Nora Therapeutics, a now-defunct biotechnology company based in Palo Alto and formerly VC-backed with $53.9M raised, specialized in developing therapeutics to improve maternal-fetal immune tolerance for treating IVF failure and unexplained recurrent pregnancy loss, holding 62 patent documents including methods using G-CSF to prevent pregnancy complications before ceasing operations in 2017.

Overview

Nora Therapeutics was a biotechnology company founded in 1992, focused on developing therapeutics to address unmet needs in reproductive medicine. Their platform aimed to help with IVF failure and recurrent pregnancy loss in women with a history of unexplained recurrent miscarriage. The company's approach was to optimize maternal-fetal immune tolerance, enabling physicians to assist patients with embryo implantation and pregnancy maintenance.

  • Status: Out of Business
  • Latest Deal Type: Out of Business
  • Ownership Status: Out of Business
  • Financing Status: Formerly VC-backed
  • Primary Industry: Pharmaceuticals
  • Other Industries: Drug Discovery, Therapeutic Devices
  • Verticals: FemTech, Life Sciences
  • Headquarters: 530 Lytton Avenue, 2nd floor, Palo Alto, CA 94301, United States

Valuation & Funding

  • Total Funding Raised: $53.9M

Funding Rounds

  1. 1.

    Later Stage VC (Series A)

    • Date: 01-Sep-2010
    • Amount: $34.9M
    • Stage: Product Development
    • Status: Completed
  2. 2.

    Later Stage VC (Series B)

    • Date: 17-Apr-2014
    • Amount: $18M
    • Stage: Generating Revenue
    • Status: Completed
  3. 3.

    Later Stage VC

    • Date: 13-Oct-2015
    • Stage: Generating Revenue
    • Status: Completed
  4. 4.

    Out of Business

    • Date: 01-Jan-2017
    • Status: Out of Business
    • Stage: Out of Business

Cap Table

  • Series A and Series B stock were authorized, but specific details are not provided.

Patents

  • Total Documents (Applications and Grants): 62
  • Total Patent Families: Not specified
  • Granted: 17
  • Pending: Not specified
  • Expiring in next 12 months: Not specified

Recent Patent Activity

  • WO-2015057724-A1: Use of g-csf for treating or preventing villitis of unknown etiology in a human female (Inactive, filed 14-Oct-2013)
  • WO-2010126528-A1: Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination (Inactive, filed 01-May-2009)
  • WO-2010126528-A9: Compositions and methods for reducing the likelihood of implantation failure or miscarriage in recipients of artificial insemination (Inactive, filed 01-May-2009)
  • WO-2010126553-A1: Compositions and methods for reducing the likelihood of implantation failure or spontaneous abortion in recipients of assisted reproduction (Inactive, filed 01-May-2009)
  • EP-2274325-A1: Human g-csf analogs and methods of making and using thereof (Inactive, filed 13-May-2008, Technology: C07K14/535)

FAQs

When was Nora Therapeutics founded?

Nora Therapeutics was founded in 1992.

Where is Nora Therapeutics headquartered?

Nora Therapeutics is headquartered in Palo Alto, CA.

What industry is Nora Therapeutics in?

Nora Therapeutics’s primary industry is Pharmaceuticals.

Is Nora Therapeutics a private or public company?

Nora Therapeutics is a Private company.

What is Nora Therapeutics’s current revenue?

The current revenue for Nora Therapeutics is not specified.

How much funding has Nora Therapeutics raised over time?

Nora Therapeutics has raised $53.9M.